Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife Defends Reputation Against Investor’s “Misrepresentations”

This article was originally published in The Tan Sheet

Executive Summary

Herbalife executives dispute allegations by activist investor William Ackman, who is short-selling the firm’s stock. Another investor, Third Point, comes to Herbalife’s defense with the acquisition of an 8.24% stake.

You may also be interested in...



Markey Calls For Herbalife “Pyramid Scheme” Investigation

The Massachusetts Democrat Jan. 22 asked Herbalife for information about its compensation system and sales to non-distributors, and urged the Securities and Exchange Commission and Federal Trade Commission to investigate the company’s marketing practices.

Markey Calls For Herbalife “Pyramid Scheme” Investigation

The Massachusetts Democrat Jan. 22 asked Herbalife for information about its compensation system and sales to non-distributors, and urged the Securities and Exchange Commission and Federal Trade Commission to investigate the company’s marketing practices.

In Brief

Vitamin Shoppe buys Super Supplements; investor Ackman wages war on Herbalife; NPA cancels MarketPlace show; Herbalife acquires N.C. facility; Capsugel expands quality control; AHP releases aloe vera monograph standard: more news In Brief.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106172

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel